EuroSafe Imaging 2020 / ESI-00429
An update on European research on Implications of Medical Low Dose Radiation Exposure (MEDIRAD)
EuroSafe Imaging 2020
Action 9 - Facilitation of research in advanced topics of radiation protection, Radiation Protection, Action 13 - Stakeholder engagement and collaboration, Radioprotection / Radiation dose
E. Cardis, G. Frija, European Institute for Biomedical Imaging Research (EIBIR)
MEDIRAD – the first EURATOM project dedicated to researching the implications of medical low-dose radiation – specifically aims to enhance the scientific bases and clinical practice of radiation protection in the medical field and addresses the need to better understand and evaluate the health effects of low-dose ionising radiation exposure from diagnostic and therapeutic imaging, and from off-target effects in radiotherapy. MEDIRAD has three major operational objectives: 1) to improve organ dose estimation and registration; 2) to evaluate and understand the mechanisms of the effects of medical radiation exposures, particularly on the cardiovascular system; and 3) to develop science-based policy recommendations for effective radiation protection.